Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milan Macek

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 28, 2016
A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screeningSophia Weidler, Konrad H Stopsack, Jutta Hammermann, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 9, 2016
Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based studyTomáš Mlčoch, Jiří Klimeš, Libor Fila, et al.
Frontiers in Medicine|January 3, 2024
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the <i>NPHS2</i> gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhoodDana Thomasová, Michaela Zelinová, Malgorzata Libik, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2013
Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populationsOlaf Sommerburg, Veronika Krulisova, Jutta Hammermann, et al.
European Journal of Human Genetics : EJHG|November 13, 2004
A large-scale study of the random variability of a coding sequence: a study on the CFTR geneGuido Modiano, Cristina Bombieri, Bianca Maria Ciminelli, et al.
Journal of Medical Genetics|September 15, 2010
Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epitheliaFrauke Stanke, Tim Becker, Vinod Kumar, et al.
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
European Journal of Human Genetics : EJHG|December 14, 2025
Cascade counselling and testing. Recommendations of the European Society of Human GeneticsGuido de Wert, Carla G van El, Angus Clarke, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV<sub>1</sub>) in cystic fibrosis patients receiving ivacaftor treatmentBéla Nagy, Zsolt Bene, Zsolt Fejes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis CentreSteven Conway, Ian M Balfour-Lynn, Karleen De Rijcke, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 28, 2016
A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screeningSophia Weidler, Konrad H Stopsack, Jutta Hammermann, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 9, 2016
Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based studyTomáš Mlčoch, Jiří Klimeš, Libor Fila, et al.
Frontiers in Medicine|January 3, 2024
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the <i>NPHS2</i> gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhoodDana Thomasová, Michaela Zelinová, Malgorzata Libik, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2013
Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populationsOlaf Sommerburg, Veronika Krulisova, Jutta Hammermann, et al.
European Journal of Human Genetics : EJHG|November 13, 2004
A large-scale study of the random variability of a coding sequence: a study on the CFTR geneGuido Modiano, Cristina Bombieri, Bianca Maria Ciminelli, et al.
Journal of Medical Genetics|September 15, 2010
Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epitheliaFrauke Stanke, Tim Becker, Vinod Kumar, et al.
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
European Journal of Human Genetics : EJHG|December 14, 2025
Cascade counselling and testing. Recommendations of the European Society of Human GeneticsGuido de Wert, Carla G van El, Angus Clarke, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV<sub>1</sub>) in cystic fibrosis patients receiving ivacaftor treatmentBéla Nagy, Zsolt Bene, Zsolt Fejes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis CentreSteven Conway, Ian M Balfour-Lynn, Karleen De Rijcke, et al.
Pageof 15